Long-Term Compassionate Use Study for Continued Administration of SCB01A-01
1 other identifier
expanded_access
N/A
0 countries
N/A
Brief Summary
The primary objective is to characterize the safety profile of long-term exposure to SCB01A when administered to cancer subjects with advanced solid tumors. Furthermore, the efficacy profile will also be explored in this study.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2010
CompletedFirst Posted
Study publicly available on registry
June 29, 2010
CompletedNovember 17, 2020
October 1, 2017
June 23, 2010
November 12, 2020
Conditions
Keywords
Interventions
This is a companion study to the protocol SCB01A-01 intended to provide long-term continued administration to subjects that completed Protocol SCB01A-01 on a compassionate basis. It is an open-label, single-arm study of SCB01A in subjects who have completed 2 cycles of treatment under the SCB01A-01 protocol.
Eligibility Criteria
You may qualify if:
- Subjects who completed protocol SCB01A-01 and exhibited a favorable response or had no clinical evidence of disease progression (i.e. stable disease, partial response or complete response).
You may not qualify if:
- Study participants meeting any of the following criteria will be excluded from enrollment:
- Unwilling or unable to provide informed consent.
- Unwilling or unable to comply with the requirements of the protocol.
- Has unresolved toxicities from previous SCB01A-01 protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Shiah HS, Chiang NJ, Lin CC, Yen CJ, Tsai HJ, Wu SY, Su WC, Chang KY, Wang CC, Chang JY, Chen LT. Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors. Oncologist. 2021 Apr;26(4):e567-e579. doi: 10.1002/onco.13612. Epub 2020 Dec 18.
PMID: 33245172DERIVED
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2010
First Posted
June 29, 2010
Last Updated
November 17, 2020
Record last verified: 2017-10